As the core method for collecting capillary blood, peripheral blood sampling is widely used in critical medical settings such as newborn disease screening, chronic disease monitoring, and auxiliary diagnosis of infectious diseases. The safety and accuracy of the sampling tools directly affect the reliability of test results and the patient’s medical experience. In recent years, next-generation disposable peripheral blood collection devices—with their user-friendly designs and technological innovations—have continuously addressed the pain points of traditional tools, playing a vital role in ensuring medical safety and improving screening efficiency. In particular, these devices provide higher-quality blood-collection solutions for special populations such as newborns and the elderly, making them essential consumables for primary healthcare and large-scale health screenings.

In clinical practice, traditional peripheral blood collection tools often encounter issues such as insufficient sample collection, blood contamination, and cumbersome operation procedures. Particularly for newborns and infants with delicate blood vessels, conventional blood collection tubes—with their poorly designed tube openings—often suffer from low blood-collection efficiency, frequently requiring repeated squeezing of the puncture site. This not only increases the child’s discomfort but may also lead to the mixing of tissue fluid, thereby compromising the accuracy of test results. Addressing this critical pain point, a domestic medical enterprise has introduced a new generation of disposable peripheral blood collection tubes that represent a technological breakthrough. These tubes feature a unique shallow arc-shaped blood-collection scraper design, enabling efficient and rapid blood sample collection. Combined with a relatively wide internal diameter, they facilitate easy control of the collected blood volume and simplify subsequent liquid-transfer operations.

In addition to improved collection efficiency, user-friendly design and enhanced safety features have become the core competitive advantages of single-use peripheral blood collection tubes. Reporters learned from several maternal and child health hospitals that mainstream peripheral blood collection tubes feature clear scale markings, enabling healthcare workers to quickly identify and precisely control the volume of blood collected. The specially designed tube caps allow for one-handed operation, significantly boosting efficiency in busy clinical settings. At the same time, these products employ a double-sealing mechanism that ensures no leakage of blood samples during storage, transportation, and centrifugation, thereby protecting operators from potential bloodborne hazards. Moreover, the interior of the tubes has undergone a special siliconization process, which not only facilitates smooth blood flow but also enables thorough mixing with pre-loaded additives simply by gently inverting the tube. Data from the neonatal department of a provincial-level maternal and child health hospital show that after introducing the new-generation single-use peripheral blood collection tubes, the average time required for blood sample collection was reduced by 40%. The rate of repeat tests due to insufficient blood volume or contamination dropped from 6.2% to 1.5%, and satisfaction among patients’ families significantly increased.

In scenarios such as newborn disease screening, primary-level management of chronic diseases, and infectious disease prevention and control, the technical advantages of single-use peripheral blood collection tubes become even more pronounced. Newborn disease screening requires heel-prick blood samples collected after 72 hours of birth to detect congenital hypothyroidism, phenylketonuria, and other inherited metabolic disorders. This process places extremely high demands on both the quality of blood samples and the safety of sample collection. The new-generation single-use peripheral blood collection tubes, when used with dedicated, single-use heel-prick lancets, feature depth-control mechanisms and ultra-thin needle designs that minimize discomfort for newborns. Combined with the tubes’ highly efficient blood-collection capabilities, a single blood sample can meet multiple testing requirements, thereby reducing the likelihood of repeated blood draws. In chronic disease management settings, such as blood glucose monitoring for patients with hepatic diabetes, these collection tubes, used in conjunction with disposable lancets, effectively reduce the risk of iatrogenic infections. Data from one hospital involving nearly a thousand monitoring sessions on 52 patients showed no instances of adverse events such as hematoma or infection at the blood-collection site. Moreover, in the auxiliary diagnosis of infectious diseases like hand, foot, and mouth disease, standardized single-use peripheral blood collection tubes ensure the safety and traceability of samples throughout the entire collection and transportation process, providing reliable sample support for rapid testing. In grassroots medical facilities located in remote areas of China, the stable storage and transportation performance of these tubes—coupled with ambient-temperature preservation technology—guarantees that blood samples maintain their testing accuracy even after long-distance transport, significantly enhancing the feasibility of grassroots chronic disease monitoring and disease screening.

The refinement of industry standards and enhanced multi-scenario adaptability are further promoting the standardized application of single-use peripheral blood collection tubes. From a global market perspective, the widespread adoption of newborn screening programs, the rising incidence of metabolic diseases, and increasingly stringent requirements for medical infection control are continuously driving growth in demand for peripheral blood collection consumables. Innovative products featuring advanced control mechanisms and cross-contamination prevention capabilities have become the industry mainstream. Domestically, related products now encompass a comprehensive product line that includes various pre-filled additives such as lithium heparin and EDTA, catering to diverse testing needs including hematology, blood glucose monitoring, and biochemical analysis. All these products have obtained Class II medical device registration certificates in China as well as international certifications such as CE and FDA. Manufacturing companies have established a full-process quality control system covering multiple stages—from material selection and GMP-compliant clean production to visual inspection—ensuring that each blood collection tube meets the highest standards for sterility. In a large-scale chronic disease screening program targeting elderly individuals conducted in a certain region, the use of standardized single-use peripheral blood collection tube kits reduced the average time required for blood collection per person by 30 seconds and increased the detection efficiency among high-risk groups by 20%, significantly alleviating the workload of primary-care healthcare workers.

Medical experts point out that the technological innovation of single-use peripheral blood collection tubes represents an important step forward for China’s medical sampling consumables toward greater precision, user-friendliness, and safety. As newborn screening coverage expands, the population ages more rapidly, and primary healthcare service capabilities strengthen, the application scenarios for peripheral blood collection will continue to broaden. In the future, with further advancements in materials technology and ergonomic design, single-use peripheral blood collection tubes are expected to achieve new breakthroughs in enhancing user comfort and expanding the range of applicable tests, thereby providing stronger technical support for safeguarding the health of special populations and bolstering public health prevention and control efforts.